We also demonstrated that targeting NFKBIB and NFKB with valproic acid (VPA, Depakine®) alone or in combination with IM achieved a better inhibitory effect on tumor growth in IM-resistant GISTs in vitro and in vivo. The gene discussed is NFKB1; the disease is neoplasm.